ARDELYX INC. - COMMON

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

17 Apr 2025 07:00:56 By Nasdaq GlobeNewswire

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

10 Apr 2025 15:02:47 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

09 Apr 2025 10:09:12 By NetDania Notify

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

07 Apr 2025 08:47:21 By NetDania Notify

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

31 Mar 2025 15:03:51 By Nasdaq GlobeNewswire

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

13 Mar 2025 07:02:40 By Nasdaq GlobeNewswire

Tenapanor Approved in China for Hyperphosphatemia

26 Feb 2025 06:00:38 By Nasdaq GlobeNewswire

Ardelyx to Participate in Upcoming Investor Conferences

25 Feb 2025 15:15:00 By Nasdaq GlobeNewswire

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

20 Feb 2025 06:30:54 By Nasdaq GlobeNewswire

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

19 Feb 2025 07:01:00 By Nasdaq GlobeNewswire

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

30 Jan 2025 15:30:00 By Nasdaq GlobeNewswire

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

13 Jan 2025 07:03:32 By Nasdaq GlobeNewswire

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ARDELYX INC. - COMMON STOCK

18 Dec 2024 10:19:26 By NetDania Notify

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

08 Nov 2024 11:31:21 By Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

05 Nov 2024 07:00:32 By Nasdaq GlobeNewswire

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

31 Oct 2024 15:02:40 By Nasdaq GlobeNewswire

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting

28 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week

24 Oct 2024 15:05:00 By Nasdaq GlobeNewswire